opportun nerv block
adjust model base nerv block analysi assumpt detail
report financi updat fda recent approv
exparel label expans interscalen brachial plexu nerv block
produc postsurg region analgesia upper extrem surgeri manag
mention signific market opportun nerv block indic would
us shoulder procedur account surgeri annual base
previou discuss physician alreadi use exparel nerv
block prior approv think increment market could smaller
summari think nerv block indic like signific
impact thesi think indic worth
nerv block view label expans exparel nerv block
posit remain cautiou much increment sale indic
gener physician alreadi use exparel off-label nerv block
current estim penetr increment annual shoulder
procedur us forecast peak sale indic
guidanc financi guidanc updat account nerv
block indic manag await visibl around impact new
indic believ impact particularli larg ep
estim increas revenu estim
increas
competit continu believ street overli optimist consensu
estim high think street continu underestim
impact competit especi believ approv
post-op analgesia instil rout like approv
clinic studi continu work addit clinic initi
exaparel soft tissu includ program involv c-section breast
reconstruct base previou physician feedback think c-section
data particular interest physician anticip top-lin result
program read later year
busi develop continu look busi develop
opportun cash end believ compani
prime posit make acquisitionw think product compani
hospit therapeut space make sens compani also look
toward world-wide opportun manag believ could sizabl
specialti pharmaceut
compani focus develop
manufactur commerci
pharmaceut product base
proprietari depofoam extend
releas drug deliveri technolog use
primarili hospit ambulatori
analyst certif import disclosur see disclosur
posit exparel abil provid long-
act analgesia reduc opioid consumpt reduc
length stay believ consensu exparel estim
high street estim may optimist due jnj/pcrx
exparel partnership orthoped procedur recent
approv exparel nerv block believ street
adequ factor competit could meaning
slow sale growth current level believ share offer
balanc risk/reward await clariti exparel
near-term growth driver along updat competit
exparel gener introduc prior
exparel receiv approv nerv block
promot effort exparel orthoped procedur lead
meaning futur growth
competitor program approv though abl
maintain major share due first mover advantag
promot effort exparel orthoped procedur
draft propos may address exparel j-
partner exparel outsid us
acquir addit accret asset complimentari exparel
promot effort exparel orthoped procedur
lead greater expect increment growth
competitor program fail late-stag clinic trial fail
exparel gener introduc prior
exparel gain approv nerv block
overpay commerci asset
promot effort exparel orthoped procedur
lead modest increment growth
program approv offer
improv exparel durat benefit length stay
gener posit exparel demonstr abil provid long-
act analgesia post-op set reduc overal opioid consumpt
reduc patient length stay believ consensu exparel estim high
street estim may overli optimist due jnj/pcrx partnership exparel
orthoped procedur recent approv exparel interscalen nerv
block despit posit believ street adequ factor
competit could meaning slow sale growth current level believ
share offer balanc risk/reward await clariti exparel near-term growth
driver along updat competit program get construct
exparel recent fda approv interscalen brachial plexu nerv block
use primarili analgesia upper bodi surgeri think investor interest
hear potenti impact stock price report attempt provid
analysi differ scenario determin valu nerv block indic
summari think nerv block opportun could worth
believ addit nerv block indic like signicantli impact
even nerv block account model consensu number remain
high opinion continu think consensu underestim
impact addit competitor post-surg analgesia space would
rather remain sidelin point
expect nerv block indic move needl much
per invest thesi still think consensu number high
farthest go consensu sale exparel sale estim lower
consensu vs believ much differ due
assumpt upcom competit post-op analgesia market think
market entrant could significantli slow growth trajectori exparel nerv
block infiltr rout administr
factset opco research
manag previous mention signific market opportun interscalen
brachial plexu nerv block lie within shoulder surgeri perform annual
us base previou talk physician portion alreadi use exparel
nerv block off-label prior recent approv sale would alreadi
includ revenu report compani would increment
exparel sale therefor despit shoulder surgeri us think
actual market opportun smalleraround total amount
shoulder surgeri perform expect abl leverag compani
relationship anesthesiologist jnj relationship orthoped surgeon
drive market penetr due exist custom relationship smaller market
size allow focus effici market penetr assum
exparel abl gain increment market share base
assumpt forecast nerv block indic reach peak
sale locat exhibit also includ bull/bear peak sale
estim look scenario base chang percent procedur
increment nerv block market penetr exparel
valuat nerv block indic base case assum exparel
nerv block worth arriv valuat use npv analysi
termin valu discount rate scenario
analysi use probabl weight valuat sum probabl adjust npv
scenario reach similar valuat exparel nerv block
exhibit exparel nerv block valuat scenario
market penetr nerv block shoulder procedures- procedur increment bearbasebullincrement weight
exhibit exparel nerv block market model
compani inform oppenheim research estim
base manag estim assum total shoulder procedur us annual expect futur growth rel flat forecast period
assum us shoulder procedur increment nerv block indic physician use exparel off-label approv alreadi
assum exparel captur us shoulder procedur market exclud procedur may alreadi use exparel even approv
wac base pricerx data price exparel assum y/i growth rate price
assum exparel nerv block peak sale
nerv block model shoulder procedur growth use exparel off-label shoulder procedur increment exparel use exparel share total exparel vial wac price growth gross-to-net discount price nerv block sale mm inc
chang model
compani inform opco estim
compani inform opco estim
compani inform opco estim
figur except per share data
sale
sale
sale
sale
compani inform oppenheim research estim
stock price compani mention report
